The most important serious adverse events associated with the treatment of drug winstrol v , were: pulmonary embolism (1%), thrombocytopenia (1%), tumor haemorrhage (0.9%), febrile neutropenia (0.4%) and hypertension (0.4%).
In 2% of cases in patients with metastatic renal cell carcinoma have been described venous thromboembolism: pulmonary embolism – two patients and deep vein thrombosis (grade 3) – two patients. In patients with gastrointestinal stromal tumor treated with sunitinib, venous thromboembolism was observed in seven patients (3%). Five of the seven celebrated deep vein thrombosis 3 degrees, and in two patients -. 1 or 2 degrees
The most common side effects at all levels associated with the treatment (marked in more than 20% of patients) were fatigue, gastrointestinal intestinal disorders such as diarrhea, nausea, stomatitis, dyspepsia, and vomiting, as well as a violation of skin pigmentation; rash; palmar-plantar syndrome eritrodizestezii; dry skin; changing hair color; inflammation of the mucous membranes;asthenia, violation taste and anorexia.
In patients with solid tumors, the most common side winstrol v effects associated with therapy , were fatigue, hypertension and neutropenia up to 3 degrees of severity and improvement of the lipase activity of up to 4 stepeni.Pobochnye events associated with sunitinib treatment, noted in clinical trials at least in> 5% of patients with solid tumors, are listed below and are organized by system-organ class, frequency and severity.
Within each group, the side effects are arranged in order of decreasing severity.
On the part of the digestive system: very often – taste perversion, diarrhea, nausea, vomiting, stomatitis, mucositis, dyspepsia, abdominal pain, anorexia, constipation, glossodiniya (language neuralgia), flatulence, dry mouth; often – pain in the mouth, gastro-oesophageal reflux; rarely – pancreatitis; rarely – gastrointestinal perforation. Skin and skin appendages:very often – to change the color of the skin, hand-foot syndrome (eritrodizesteziya), rash (erythematous, spotty, papular, scaly, generalized, psoriasiform), blisters, change in hair color, dry skin, erythema;often – alopecia, skin peeling, itching, exfoliative dermatitis. From the musculoskeletal system: often – pain in the extremities, arthralgia, myalgia. From the nervous system: very often – headache; often – dizziness, paraesthesia, insomnia or hypersomnia, depression. Since the cardiovascular system: very often – increased blood pressure; often – reduced left ventricular ejection fraction , venous thromboembolism (pulmonary embolism, deep vein thrombosis); rarely – heart failure, congestive heart failure, impaired left ventricular function, rarely – lengthening the interval winstrol v, flicker and flutter of the type “pirouette”. From the urinary system: often – chromaturia (change in urine color). On the part of the respiratory system: very often – nosebleeds; often – shortness of breath, guttural, pharyngeal pain. On the part of the endocrine system: often – hypothyroidism, increased levels of thyroid-stimulating hormone.
Other: very often – asthenia / fatigue, increased lipase activity in blood serum; often – watery eyes, weight loss, flu, fever, chills, peripheral edema, periorbital edema, dehydration, serum creatine phosphokinase increased activity and amylase activity; rarely – bleeding from the tumors, flu-like symptoms.Patients with brain metastases or reversible leukoencephalopathy syndrome cases seizures are described. The results of post-marketing studies during the application of sunitinib after its registration the following adverse events were recorded. Running low dose t3 clen cycle trying to lose bodyfat isn’t a real hot idea imo.